Detalhe da pesquisa
1.
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Carcinogenesis
; 41(11): 1529-1542, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603404
2.
Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.
Int J Cancer
; 142(7): 1405-1417, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29134640
3.
T helper 17 cells play a critical pathogenic role in lung cancer.
Proc Natl Acad Sci U S A
; 111(15): 5664-9, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24706787
4.
Efficient blockade of akt signalling is a determinant factor to overcome resistance to matuzumab
Mol cancer
; 10: 151-151, 2011.
Artigo
em Inglês
| TXTC | ID: txt-25420
5.
Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase.
Mol Cancer
; 12(1): 154, 2013 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24321240
6.
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.
BMC Cancer
; 12: 507, 2012 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23130941
7.
OBIF: an omics-based interaction framework to reveal molecular drivers of synergy.
NAR Genom Bioinform
; 4(2): lqac028, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387383
8.
Efficient blockade of Akt signaling is a determinant factor to overcome resistance to matuzumab.
Mol Cancer
; 10: 151, 2011 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22185378
9.
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106386
10.
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Int J Radiat Oncol Biol Phys
; 104(4): 903-912, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905636
11.
Altered cancer metabolism in mechanisms of immunotherapy resistance.
Pharmacol Ther
; 195: 162-171, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30439456
12.
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
Clin Cancer Res
; 25(24): 7576-7584, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540976
13.
Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy.
Immunotherapy
; 10(10): 851-0, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073899
14.
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.
Cancer Lett
; 431: 54-63, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746927
15.
COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation.
Oncotarget
; 9(68): 32972-32983, 2018 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30250643
16.
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer.
Nat Commun
; 9(1): 4589, 2018 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30389925
17.
IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties.
Cancer Immunol Res
; 6(7): 788-797, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29764837
18.
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.
Clin Cancer Res
; 24(22): 5735-5743, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784675
19.
Requirement for MUC5AC in KRAS-dependent lung carcinogenesis.
JCI Insight
; 3(15)2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30089720
20.
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Cancer Res
; 76(11): 3189-99, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27197187